Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations

BACKGROUND: Chagas disease (CD), caused by the parasite Trypanosoma cruzi, is a serious public health concern in Latin America. Nifurtimox and benznidazole (BZ), the only two drugs currently approved for the treatment of CD, have very low efficacies in the chronic phase of the disease and several to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Davi Alvarenga, Gonçalves, Leilane Oliveira, Reis-Cunha, João Luís, Guimarães, Paul Anderson Souza, Ruiz, Jeronimo Conceição, Liarte, Daniel Barbosa, Murta, Silvane Maria Fonseca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204194/
https://www.ncbi.nlm.nih.gov/pubmed/37217925
http://dx.doi.org/10.1186/s13071-023-05775-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204194/
https://www.ncbi.nlm.nih.gov/pubmed/37217925
http://dx.doi.org/10.1186/s13071-023-05775-4

Ejemplares similares